Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth N Allen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Cochrane Database of Systematic Reviews|September 8, 2022
Adding rapid diagnostic tests to community-based programmes for treating malariaElizabeth N Allen, Alison Beriliy Wiyeh, Michael McCaul
The Cochrane Database of Systematic Reviews|January 27, 2018
Eliciting adverse effects data from participants in clinical trialsElizabeth N Allen, Clare Ir Chandler, Nyaradzo Mandimika, et al.
Malaria Journal|January 29, 2017
Working towards consensus on methods used to elicit participant-reported safety data in uncomplicated malaria clinical drug studies: a Delphi technique studyNyaradzo Mandimika, Karen I Barnes, Clare I R Chandler, et al.
Malaria Journal|June 30, 2009
Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trialElizabeth N Allen, Francesca Little, Tunisio Camba, et al.
Malaria Journal|September 18, 2013
Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related dataElizabeth N Allen, Clare I R Chandler, Nyaradzo Mandimika, et al.
BMC Health Services Research|November 5, 2014
Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative studyElizabeth N Allen, Melba Gomes, Lucy Yevoo, et al.
BMC Medical Research Methodology|November 16, 2013
How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trialsElizabeth N Allen, Adiel K Mushi, Isolide S Massawe, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated MalariaMiné de Kock, Joel Tarning, Lesley Workman, et al.
Malaria Journal|March 20, 2021
Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauf, et al.
Malaria Journal|January 7, 2021
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauff, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Cochrane Database of Systematic Reviews|September 8, 2022
Adding rapid diagnostic tests to community-based programmes for treating malariaElizabeth N Allen, Alison Beriliy Wiyeh, Michael McCaul
The Cochrane Database of Systematic Reviews|January 27, 2018
Eliciting adverse effects data from participants in clinical trialsElizabeth N Allen, Clare Ir Chandler, Nyaradzo Mandimika, et al.
Malaria Journal|January 29, 2017
Working towards consensus on methods used to elicit participant-reported safety data in uncomplicated malaria clinical drug studies: a Delphi technique studyNyaradzo Mandimika, Karen I Barnes, Clare I R Chandler, et al.
Malaria Journal|June 30, 2009
Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trialElizabeth N Allen, Francesca Little, Tunisio Camba, et al.
Malaria Journal|September 18, 2013
Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related dataElizabeth N Allen, Clare I R Chandler, Nyaradzo Mandimika, et al.
BMC Health Services Research|November 5, 2014
Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative studyElizabeth N Allen, Melba Gomes, Lucy Yevoo, et al.
BMC Medical Research Methodology|November 16, 2013
How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trialsElizabeth N Allen, Adiel K Mushi, Isolide S Massawe, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated MalariaMiné de Kock, Joel Tarning, Lesley Workman, et al.
Malaria Journal|March 20, 2021
Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauf, et al.
Malaria Journal|January 7, 2021
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauff, et al.
Pageof 2